Pharma Co. To Pay $46M Over Transplant Drug Kickbacks
Veloxis Pharmaceuticals Inc. will enter a deferred prosecution agreement and pay more than $46 million to resolve criminal and civil allegations that the North Carolina-based drug manufacturer paid kickbacks to spur...To view the full article, register now.
Already a subscriber? Click here to view full article